In addition, ccRCC tumors resistant to sunitinib exhibited increased IL8 expression and increased plasma levels of IL8 in mice with sunitinib-resistant tumors compared to mice bearing sunitinib-sensitive tumors [36]. The gene discussed is CXCL8; the disease is nonpapillary renal cell carcinoma.